Search
Search Funnelback University
- Refined by:
- Date: 2022
31 -
50 of
228
search results for `news stories`
Fully-matching results
-
KARPAS 707H Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-707h-human-myeloma-cell-line/9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.
-
KARPAS 1272 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-1272-human-myeloma-cell-line/9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.
-
Innovate Cambridge initiative to support, promote and enhance the…
https://www.enterprise.cam.ac.uk/news/astrazeneca-and-microsoft-join-steering-committee-as-innovate-cambridge-initiative-to-support-promote-and-enhance-the-cambridge-innovation-ecosystem-on-the-global-stage-gains-momentum/8 Dec 2022: Today’s news, last night’s event, and the subsequent number of signatures we have secured for the charter to date, have confirmed that we are securing visible commitment from all
-
Queen's Birthday Honours 2022 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/queens-birthday-honours-2022/2 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 2 June 2022. Queen’s Birthday Honours 2022. Share:. Leaders in fields from chemistry to cancer research are among the Cambridge academics recognised in the 2022 Queen’s Birthday
-
KARPAS 241 Human Monoblastic cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-241-human-monoblastic-cell-line/9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.
-
Apollo Therapeutics: KE Award Winners – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/apollo-therapeutics-ke-award-winners/1 Mar 2022: Apollo Therapeutics was awarded PraxisAuril's ‘KE Deal of the Year’ for the $145m fundraising round it closed in 2021.
-
DIOSynVax: tackling COVID-19 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/11 Apr 2022: Case study of DIOSynVax, a University of Cambridge spin-out founded by Professor Heeney, which is developing a vaccine for COVID-19.
-
Sustainability, investment and the Carbon Challenge – Cambridge…
https://www.enterprise.cam.ac.uk/video/sustainability-investment-and-the-carbon-challenge/12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.
-
Human CD59 monoclonal antibody YTH 53.1
https://www.enterprise.cam.ac.uk/reagents/human-cd59-monoclonal-antibody-yth-53-1/9 May 2022: Hybridoma cell line producing YTH 53.1 antibodies raised against human CD59 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD7 monoclonal antibody YTH 30.15
https://www.enterprise.cam.ac.uk/reagents/human-cd7-monoclonal-antibody-yth-30-15/9 May 2022: Hybridoma cell line producing YTH 30.15 antibodies raised against human CD7 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD11a monoclonal antibody YTH 81.5
https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.
-
Human CD16 monoclonal antibody YFC 120.5
https://www.enterprise.cam.ac.uk/reagents/human-cd16-monoclonal-antibody-yfc-120-5/9 May 2022: Hybridoma cell line producing YFC 120.5 antibodies raised against human CD16 which are rat monoclonal antibodies of the IgG2b isotype.
-
Rat CD45 monoclonal antibody YTH 24.5
https://www.enterprise.cam.ac.uk/reagents/human-cd45-monoclonal-antibody-yth-24-5/9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
-
CAM2 software for hearing aid fitting – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/9 May 2022: CAM2 software is a package that enables hearing aids to be tailored to an individual’s needs, resulting in improved hearing quality.
-
Human CD18 monoclonal antibody YFC 118.12
https://www.enterprise.cam.ac.uk/reagents/human-cd18-monoclonal-antibody-yfc-118-12/9 May 2022: Hybridoma cell line producing YFC118.12 antibodies raised against human CD18 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD28 monoclonal antibody YTH 913.12
https://www.enterprise.cam.ac.uk/reagents/human-cd28-monoclonal-antibody-yth-913-12/9 May 2022: Hybridoma cell line producing YTH 913.12 antibodies raised against human CD28 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD235a monoclonal antibody YTH 89.1
https://www.enterprise.cam.ac.uk/reagents/human-cd235a-monoclonal-antibody-yth-89-1/9 May 2022: Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are rat monoclonal antibodies of the IgG2b isotype.
-
COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cobras-concrete-bridge-assessment-program/9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.
-
Rat CD45 monoclonal antibody YTH 54.12
https://www.enterprise.cam.ac.uk/reagents/mouse-cd45-monoclonal-antibody-yth-54-12/9 May 2022: Hybridoma cell line producing YTH 54.12 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.
-
Human CD66acd monoclonal antibody YTH 71.3
https://www.enterprise.cam.ac.uk/reagents/human-cd66acd-monoclonal-antibody-yth-71-3/9 May 2022: Hybridoma cell line producing YTH 71.3 antibodies raised against human CD66acd which are rat monoclonal antibodies of the IgG2a isotype.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.